Related Experiment Video
Updated: Oct 31, 2025

Examination of Proteins Bound to Nascent DNA in Mammalian Cells Using BrdU-ChIP-Slot-Western Technique
Published on: January 14, 2016
KDM5A and KDM5B histone-demethylases contribute to HU-induced replication stress response and tolerance
Solenne Gaillard1, Virginie Charasson1, Cyril Ribeyre2
1MCD, Centre de Biologie Integrative (CBI), University of Toulouse, CNRS, UPS, 31062 Toulouse, France.
Abstract:
KDM5A and KDM5B histone-demethylases are overexpressed in many cancers and have been involved in drug tolerance. Here, we describe that KDM5A, together with KDM5B, contribute to replication stress (RS) response and tolerance. First, they positively regulate RRM2, the regulatory subunit of ribonucleotide reductase. Second, they are required for optimal levels of activated Chk1, a major player of the intra-S phase checkpoint that protects cells from RS. We also found that KDM5A is enriched at ongoing replication forks and associates with both PCNA and Chk1. Because RRM2 is a major determinant of replication stress tolerance, we developed cells resistant to HU, and show that KDM5A/B proteins are required for both RRM2 overexpression and tolerance to HU. Altogether, our results indicate that KDM5A/B are major players of RS management. They also show that drugs targeting the enzymatic activity of KDM5 proteins may not affect all cancer-related consequences of KDM5A/B overexpression.
Insights
KDM5A and KDM5B proteins manage replication stress (RS) by regulating RRM2 and Chk1. These demethylases are crucial for cancer cells to tolerate RS, impacting drug resistance.
Area of Science:
- Molecular Biology
- Cancer Biology
- Biochemistry
Background:
- KDM5A and KDM5B histone demethylases are overexpressed in various cancers.
- These enzymes are implicated in cancer drug tolerance mechanisms.
Purpose of the Study:
- To investigate the role of KDM5A and KDM5B in the cellular response to replication stress (RS).
- To elucidate the mechanisms by which KDM5A/B contribute to RS tolerance.
Main Methods:
- Analysis of KDM5A/B roles in regulating RRM2 and Chk1 activation.
- Biochemical assays to determine KDM5A enrichment at replication forks and association with PCNA and Chk1.
- Development and analysis of hydroxyurea (HU)-resistant cell models.
Main Results:
- KDM5A and KDM5B positively regulate RRM2, the regulatory subunit of ribonucleotide reductase.
- KDM5A/B are essential for optimal activated Chk1 levels, a key component of the intra-S phase checkpoint.
- KDM5A localizes to replication forks and interacts with PCNA and Chk1.
- KDM5A/B are required for RRM2 overexpression and HU resistance in tolerant cells.
Conclusions:
- KDM5A/B are critical regulators of replication stress (RS) management.
- Targeting KDM5 enzymatic activity may not fully address all cancer-related consequences of KDM5A/B overexpression.
Related Concept Videos
The DNA Replication Fork
DNA Helicases
Restarting Stalled Replication Forks
Spreading of Chromatin Modifications
Writers
The writer...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...

